Literature DB >> 19358610

Halogen bonding--a novel interaction for rational drug design?

Yunxiang Lu1, Ting Shi, Yong Wang, Huaiyu Yang, Xiuhua Yan, Xiaoming Luo, Hualiang Jiang, Weiliang Zhu.   

Abstract

Although recognized in small molecules for quite some time, the implications of halogen bonding in biomolecular systems are only now coming to light. In this study, several systems of proteins in complex with halogenated ligands have been investigated by using a two-layer QM/MM ONIOM methodology. In all cases, the halogen-oxygen distances are shown to be much less than the van der Waals radius sums. Single-point energy calculations unveil that the interaction becomes comparable in magnitude to classical hydrogen bonding. Furthermore, we found that the strength of the interactions attenuates in the order H approximately I > Br > Cl. These results agree well with the characteristics discovered within small model halogen-bonded systems. A detailed analysis of the interactions reveals that halogen bonding interactions are responsible for the different conformation of the molecules in the active site. This study would help to establish such interaction as a potential and effective tool in the context of drug design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358610     DOI: 10.1021/jm9000133

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  74 in total

1.  Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335.

Authors:  Christopher T Lemke; Nathalie Goudreau; Songping Zhao; Oliver Hucke; Diane Thibeault; Montse Llinàs-Brunet; Peter W White
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

2.  Anion recognition based on halogen bonding: a case study of macrocyclic imidazoliophane receptors.

Authors:  Yunxiang Lu; Haiying Li; Xiang Zhu; Honglai Liu; Weiliang Zhu
Journal:  J Mol Model       Date:  2012-01-18       Impact factor: 1.810

3.  Molecular mechanical perspective on halogen bonding.

Authors:  Mahmoud A A Ibrahim
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

4.  Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.

Authors:  Shao-Xu Huang; Hui-Yuan Li; Jun-Yan Liu; Christophe Morisseau; Bruce D Hammock; Ya-Qiu Long
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

5.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

6.  Synergistic and diminutive effects between halogen bond and lithium bond in complexes involving aromatic compounds.

Authors:  Mingxiu Liu; Mengyang Cai; Qingzhong Li; Wenzuo Li; Jianbo Cheng
Journal:  J Mol Model       Date:  2015-09-14       Impact factor: 1.810

7.  Cooperative effects between halogen bonds and pnicogen bonds in XBr∙∙∙OFH2P∙∙∙NH3 (X = F, Cl, CN, NC, OH, and NO2) complexes.

Authors:  Qiang Zhao
Journal:  J Mol Model       Date:  2015-12-09       Impact factor: 1.810

8.  A quantum mechanics-based halogen bonding scoring function for protein-ligand interactions.

Authors:  Zhuo Yang; Yingtao Liu; Zhaoqiang Chen; Zhijian Xu; Jiye Shi; Kaixian Chen; Weiliang Zhu
Journal:  J Mol Model       Date:  2015-05-10       Impact factor: 1.810

9.  Treatment of Halogen Bonding in the OPLS-AA Force Field; Application to Potent Anti-HIV Agents.

Authors:  William L Jorgensen; Patric Schyman
Journal:  J Chem Theory Comput       Date:  2012-04-03       Impact factor: 6.006

Review 10.  Halogen bonding (X-bonding): a biological perspective.

Authors:  Matthew R Scholfield; Crystal M Vander Zanden; Megan Carter; P Shing Ho
Journal:  Protein Sci       Date:  2012-12-29       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.